BNF - Chapter 2 - Cardiovascular System (Part 2) Flashcards
What is cardiovascular disease (CVD)?
it is a term that describes a group of disorders of the heart and blood vessels caused by atherosclerosis and thrombosis, which includes coronary heart disease, stroke, peripheral arterial disease, and aortic disease
Which groups is the risk of CVD greater in?
- Men
- Patients with a family history of CVD
- Certain ethnic backgrounds such as South Asians
- patients aged over 50 years and increases with age
- Patients aged 85 years and over are at high risk
What are some modifiable risk factors of CVD?
- Hypertension
- Abnormal Lipids
- Obesity
- Diabetes Mellitus
- Psychosocial factors such as depression, anxiety and social isolation
- Low physical activity
- Poor diet
- Smoking
- Excessive alcohol intake
Priority for a full formal risk assessment of CVD should be given to which patients?
- patients with an estimated 10-year risk of 10% or more.
After what age should patients have their estimate of CVD risk reviewed on an ongoing basis?
- Patients aged over 40 years
Instead, what does SIGN 2017 recommend on the frequency of CVD risk assessment?
CVD risk assessments are offered at least every 5 years to all patients aged 40 years and over with no history of CVD, familial hypercholesterolaemia, chronic kidney disease or diabetes and who are not receiving treatment to reduce blood pressure or lipids. As well as to patients with a first-degree relative who has premature atherosclerotic CVD or familial dyslipidaemia, regardless of their age.
Is a risk assessment with a calculator required in patients who are at increased or high risk of CVD?
Risk assessment with a calculator is not required in patients who are at increased or high risk of CVD. This includes those with established CVD, chronic kidney disease stage 3 or higher (eGFR <60 mL/minute/1.73 m2), albuminuria, or familial hypercholesterolaemia. In addition to these patients, NICE (2016) do not recommend the use of a risk calculator in patients with other hereditary disorders of lipid metabolism, or type 1 diabetes mellitus. Whereas SIGN (2017) do not recommend the use of a risk calculator in patients with diabetes mellitus aged 40 years and over, and in those aged under 40 years with diabetes mellitus who have either had it for more than 20 years, present with target organ damage (such as proteinuria, albuminuria, proliferative retinopathy, or autonomic neuropathy), or have other significantly elevated cardiovascular risk factors.
What are CVD risk assessment calculators used for?
They are used to predict the approximate likelihood of a cardiovascular event occurring over a given period of time
In which patient may CVD risk be underestimated in?
- patients with additional risk due to conditions or medications that can cause dyslipidaemia (e.g. antipsychotics, corticosteroids, or immunosuppressants).
- Patients who are already taking anti-hypertensives or lipid-regulating drugs or who have recently stopped smoking
Which Risk calculators are used in England and Wales?
QRISK 2 and JBS3
What conditions do these two risk calculators assess?
- CVD risk of coronary heart disease (Angina and myocardial infarction)
- stroke and TIA
What factors are taken into account in the risk calculators?
- Lipid profile
- systolic blood pressure
- Gender
- Age
- Ethnicity
- Smoking status
- BMI
- Chronic kidney disease (stage 4 or above)
- Diabetes mellitus
- Atrial fibrillation
- treated hypertension
- Rheumatoid arthritis
- Social deprivation
- family history of premature CVD
What additional info does the updated QRISK 3 include?
It considers additional risk factors such as chronic kidney disease (stage 3 or above), migraine, corticosteroid use, systemic lupus erythematosus, atypical antipsychotics use, severe mental illness, erectile dysfunction, and a measure of systolic blood pressure variability.
What is the advantage of JBS3 calculator?
The JBS3 calculator is not only able to estimate short term (10-year) risk, but also lifetime risk of CVD events.
Which patients may benefit from a JBS3 calculator?
Patients with a 10-year risk of CVD of less than 10% may benefit from an assessment of their lifetime risk using the JBS3 tool, and a discussion on the impact of lifestyle interventions and, if necessary, drug therapy.
What is the ASSIGN cardiovascular risk assessment calculator?
It is tailored to the Scottish population and uses factors such as age, sex, smoking, systolic blood pressure, lipid profile, family history of premature CVD, diabetes mellitus, rheumatoid arthritis, and social deprivation to estimate cardiovascular risk. Other risk factors not included in this CVD risk assessment calculator (such as ethnicity, BMI, atrial fibrillation, psychological wellbeing, and physical inactivity) should also be taken into account when assessing and managing the patient’s overall CVD risk.
What are all patients at any risk of CVD advised to make?
Should be advised to make lifestyle modifications that may include beneficial changes to diet (such as increasing fruit and vegetable consumption, reducing saturated fat and dietary salt intake), increasing physical exercise, weight management, reducing alcohol consumption, and Smoking cessation.
What often should a review to discuss lifestyle modification, medication adherence and risk factors be done?
An annual review should be considered to discuss lifestyle modification, medication adherence and risk factors. The frequency of review may be tailored to the individual.
Is aspirin recommended for the primary prevention of CVD?
No - Aspirin is not recommended for primary prevention of CVD due to the limited benefit gained versus risk of side-effects such as bleeding.
For Primary prevention what two pharmacological therapy can be used?
- Antihypertensive therapy
- Lipid-lowering therapy
Which patients should be given antihypertensive drugs as primary prevention?
- Antihypertensive drug treatment should be offered to patients who are at high risk of CVD and have a sustained elevated systolic blood pressure over 140 mmHg and/or diastolic blood pressure over 90 mmHg. For
Before starting a lipid-lowering therapy for primary prevention of CVD what factors should be managed first?
All modifiable risk factors, comorbidities and secondary causes of dyslipidaemia (e.g. uncontrolled diabetes mellitus, hepatic disease, nephrotic syndrome, excessive alcohol consumption, and hypothyroidism) should be managed before starting treatment with a statin. Factors such as polypharmacy, frailty, and comorbidities should be taken into account before starting statin therapy.
To which patients is a low dose atorvastatin recommended to start in for primary prevention of CVD?
for patients who have a 10% or greater 10-year risk of developing CVD (using the QRISK2 calculator), and for patients with chronic kidney disease.
- Low-dose atorvastatin should be considered in all patients with type 1 diabetes mellitus, and be offered to patients with type 1 diabetes who are either aged over 40 years, have had diabetes for more than 10 years, have established nephropathy, or have other CVD risk factors.
Patients aged 85 years and over may also benefit from low-dose atorvastatin to reduce their risk of non-fatal myocardial infarction. SIGN (2017) recommend low-dose atorvastatin for patients who are considered to be at high risk of CVD and not on dialysis.
How often should patients that are taking statins have a review?
Annual medication review, to discuss medication adherence, lifestyle modifications, CVD risk factors, and non-fasting, non-HDL cholesterol concentration (if testing deemed appropriate)